eLifeNeurosciencePeer-reviewed journal article
Ketamine induces multiple individually distinct whole-brain functional connectivity signatures
Flora MoujaesiD, Jie Lisa JiiD, Masih RahmatiiD, Joshua B. BurtiD, Charles H. SchleiferiD, Brendan D. AdkinsoniD, Aleksandar SavićiD, Nicole P. Santamauro, Zailyn Tamayo, Caroline DiehliD, Antonija KolobariciD, Morgan Flynn, Nathalie M. RieseriD, Clara FonteneauiD, Terry Camarro, Junqian XuiD, Youngsun ChoiD, Grega RepovšiD, Sarah Kathryn FinebergiD, PETER T. MORGANiD, Erich SeifritziD, Franz X. VollenweideriD, John Harrison KrystaliD, John D. MurrayiD, Katrin H. PrelleriD, Alan AnticeviciD
Abstract
BackgroundKetamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it is unclear how ketamines molecular mechanisms connect to its neural and behavioral effects. MethodsWe conducted a double-blind placebo-controlled study in which 40 healthy participants received acute ketamine (initial bolus 0.23 mg/kg, continuous infusion 0.58 mg/kg/hour). We quantified resting-state functional connectivity via data-driven global brain connectivity, related it to individual ketamine-induced symptom variation, and compared it to cortical gene expression targets. ResultsWe found that: i) both the neural and behavioral effects of acute ketamine are multi-dimensional, reflecting robust inter-individual variability; ii) ketamines data-driven principal neural gradient effect matched somatostatin (SST) and parvalbumin (PVALB) cortical gene expression patterns in humans, implicating the role of SST and PVALB interneurons in ketamines acute effects; and iii) behavioral data-driven individual symptom variation mapped onto distinct neural gradients of ketamine, which were resolvable at the single-subject level. ConclusionsCollectively, these findings support the possibility for developing individually precise pharmacological biomarkers for treatment selection in psychiatry. FundingThis study was supported by NIH grants DP5OD012109-01 (A.A.), 1U01MH121766 (A.A.), R01MH112746 (J.D.M.), 5R01MH112189 (A.A.), 5R01MH108590 (A.A.), NIAAA grant 2P50AA012870-11 (A.A.); NSF NeuroNex grant 2015276 (J.D.M.); Brain and Behavior Research Foundation Young Investigator Award (A.A.); SFARI Pilot Award (J.D.M., A.A.); Heffter Research Institute (Grant No. 1-190420); Swiss Neuromatrix Foundation (Grant No. 2016-0111m Grant No. 2015 - 010); Swiss National Science Foundation under the frame-work of Neuron Cofund (Grant No. 01EW1908), Usona Institute (2015 - 2056).
- Citations
- 27
- FWCI
- 7.06
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Acute Ketamine Modulated Functional Brain Coupling and Dissociative and Affective States in Human Subjects: Interim Analyses
Laura M. Hack, Katherine Warthen, … Leanne Maree Williams·bioRxiv·Sep 20, 2021
- Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system
Malika S. Datta, Yannan Chen, … Raju Tomer·Cell ReportsPeer-reviewed·Dec 1, 2023
- Characterizing ketamine-induced dissociation using human intracranial neurophysiology: brain dynamics, network activity, and interactions with propofol
Fangyun Tian, Laura D. Lewis, … Patrick L. Purdon·bioRxiv·May 2, 2022
- Ketamine's pharmacogenomic network in human brain contains sub-networks associated with glutamate neurotransmission and with neuroplasticity
G. A. Higgins, S. K. Handelman, … B. D. Athey·bioRxiv·Apr 28, 2020
- Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach
Claudio Agnorelli, Joseph M. Peill, … David Erritzøe·bioRxiv·May 1, 2025
- Acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans: A TD-fNIRS neuroimaging study
Adelaida Castillo, Julien Dubois, … Moriah Taylor·Scientific ReportsPeer-reviewed·Jul 19, 2023